» Articles » PMID: 22576591

Lower Treatment Intensity and Poorer Survival in Metastatic Colorectal Cancer Patients Who Live Alone

Overview
Journal Br J Cancer
Specialty Oncology
Date 2012 May 12
PMID 22576591
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Socioeconomic status (SES) and social support influences cancer survival. If SES and social support affects cancer treatment has not been thoroughly explored.

Methods: A cohort consisting of all patients who were initially diagnosed with or who developed metastatic colorectal cancer (mCRC, n=781) in three Scandinavian university hospitals from October 2003 to August 2006 was set up. Clinical and socioeconomic data were registered prospectively.

Results: Patients living alone more often had synchronous metastases at presentation and were less often treated with combination chemotherapy than those cohabitating (HR 0.19, 95% CI 0.04-0.85, P=0.03). Surgical removal of metastases was less common in patients living alone (HR 0.29, 95% CI 0.10-0.86, P=0.02) but more common among university-educated patients (HR 2.22, 95% CI 1.10-4.49, P=0.02). Smoking, being married and having children did not influence treatment or survival. Median survival was 7.7 months in patients living alone and 11.7 months in patients living with someone (P<0.001). Living alone remained a prognostic factor for survival after correction for age and comorbidity.

Conclusion: Patients living alone received less combination chemotherapy and less secondary surgery. Living alone is a strong independent risk factor for poor survival in mCRC.

Citing Articles

The long-term conditional mortality rate in older ICU patients compared to the general population.

Aronsson Dannewitz A, Svennblad B, Michaelsson K, Lipcsey M, Gedeborg R Crit Care. 2024; 28(1):368.

PMID: 39543756 PMC: 11566578. DOI: 10.1186/s13054-024-05147-z.


Perioperative Evaluation of the Physical Quality of Life of Patients with Non-Small Cell Lung Cancer: A Prospective Study.

Fukai R, Nishida T, Sugimoto H, Hibino M, Horiuchi S, Kondo T Cancers (Basel). 2024; 16(8).

PMID: 38672609 PMC: 11048487. DOI: 10.3390/cancers16081527.


The Impact of Palliative Care on Mitigating Pain and Its Associated Effects in Determining Quality of Life among Colon Cancer Outpatients.

Macharia J, Raposa B, Sipos D, Melczer C, Toth Z, Kaposztas Z Healthcare (Basel). 2023; 11(22).

PMID: 37998446 PMC: 10671794. DOI: 10.3390/healthcare11222954.


The impact of sarcopenia on the outcome of patients with left-sided colon and rectal cancer after curative surgery.

Li Q, An T, Wu J, Lu W, Wang Y, Li J BMC Cancer. 2023; 23(1):640.

PMID: 37430182 PMC: 10332026. DOI: 10.1186/s12885-023-11073-0.


Optimized diagnosis-based comorbidity measures for all-cause mortality prediction in a national population-based ICU population.

Aronsson Dannewitz A, Svennblad B, Michaelsson K, Lipcsey M, Gedeborg R Crit Care. 2022; 26(1):306.

PMID: 36203163 PMC: 9535950. DOI: 10.1186/s13054-022-04172-0.


References
1.
Villingshoj M, Ross L, Thomsen B, Johansen C . Does marital status and altered contact with the social network predict colorectal cancer survival?. Eur J Cancer. 2006; 42(17):3022-7. DOI: 10.1016/j.ejca.2006.04.027. View

2.
Tilney H, Lovegrove R, Smith J, Thompson M, Tekkis P . The National Bowel Cancer Project: social deprivation is an independent predictor of nonrestorative rectal cancer surgery. Dis Colon Rectum. 2009; 52(6):1046-53. DOI: 10.1007/DCR.0b013e3181a65f41. View

3.
Eaker S, Halmin M, Bellocco R, Bergkvist L, Ahlgren J, Holmberg L . Social differences in breast cancer survival in relation to patient management within a National Health Care System (Sweden). Int J Cancer. 2008; 124(1):180-7. DOI: 10.1002/ijc.23875. View

4.
Pinquart M, Duberstein P . Associations of social networks with cancer mortality: a meta-analysis. Crit Rev Oncol Hematol. 2009; 75(2):122-37. PMC: 2910231. DOI: 10.1016/j.critrevonc.2009.06.003. View

5.
Frederiksen B, de Nully Brown P, Dalton S, Steding-Jessen M, Osler M . Socioeconomic inequalities in prognostic markers of non-Hodgkin lymphoma: analysis of a national clinical database. Eur J Cancer. 2010; 47(6):910-7. DOI: 10.1016/j.ejca.2010.11.014. View